Travere Therapeutics (TVTX) Gross Margin Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,604.00 |
| Dec 31, 2025 | 479.00 |
| Sep 30, 2025 | -164.00 |
| Jun 30, 2025 | 176.00 |
| Mar 31, 2025 | -1,233.00 |
| Dec 31, 2024 | 28.00 |
| Sep 30, 2024 | 82.00 |
| Jun 30, 2024 | -162.00 |
| Mar 31, 2024 | -107.00 |
| Dec 31, 2023 | -647.00 |
| Sep 30, 2023 | -69.00 |
| Jun 30, 2023 | -166.00 |
| Mar 31, 2023 | -922.00 |
| Dec 31, 2022 | -18.00 |
| Sep 30, 2022 | -167.00 |
| Jun 30, 2022 | -511.00 |
| Mar 31, 2022 | -702.00 |
| Dec 31, 2021 | 255.00 |
| Sep 30, 2021 | 174.00 |
| Jun 30, 2021 | 4.00 |
| Mar 31, 2021 | -86.00 |
| Dec 31, 2020 | -156.00 |
| Sep 30, 2020 | -49.00 |
| Jun 30, 2020 | -44.00 |
| Mar 31, 2020 | -129.00 |
| Dec 31, 2019 | -130.00 |
| Sep 30, 2019 | -104.00 |
| Jun 30, 2019 | -158.00 |
| Mar 31, 2019 | 64.00 |